JLE

Epileptic Disorders

MENU

Syndromes with very low risk of acute prolonged seizures Volume 16, numéro spécial 1, October 2014

  • [Agathonikou et al., 1998] Agathonikou A., Panayiotopoulos C.P., Giannakodimos S., Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia. 1998;39:1265-1276.
  • [Alldredge et al., 2001] Alldredge B.K., Gelb A.M., Isaacs S.M., Corry M.D., Allen F. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631-637.
  • [Baykan et al., 2013] Baykan B., Martínez-Juárez I.E., Altindag E.A., Camfield C.S., Camfield P.R. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav. 2013;28:18-24.
  • [Berg et al., 1999] Berg A.T., Shinnar S., Levy S.R., Testa F.M. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol. 1999;45:618-623.
  • [Berg et al., 2004] Berg A.T., Shinnar S., Testa F.M. Status epilepticus after the initial diagnosis of epilepsy in children. Neurology. 2004;28:1027-1034.
  • [Callenbach et al., 2009] Callenbach P.M., Bouma P.A., Geerts A.T. Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood. Epilepsy Res. 2009;83:249-256.
  • [Camfield and Camfield, 2009] Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology. 2009;73:1041-1045.
  • [Camfield and Camfield, 2012] Camfield P., Camfield C. Unprovoked status epilepticus: the prognosis for otherwise normal children with focal epilepsy. Pediatrics. 2012;130:e501-e506.
  • [Caraballo et al., 2000] Caraballo R., Cersosimo R., Medina C., Fejerman N. Panayiotopoulos-type benign childhood occipital epilepsy: a prospective study. Neurology. 2000;55:1096-1100.
  • [Cascino et al., 1998] Cascino G.D., Hesdorffer D., Logroscino G., Hauser W.A. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia. 1998;39:829-832.
  • [Chin et al., 2006] Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222-229.
  • [Chin et al., 2008] Chin R.F., Neville B.G., Peckham C. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol. 2008;7:696-703.
  • [Crespel et al., 2013] Crespel A., Gelisse P., Reed R.C. Management of juvenile myoclonic epilepsy. Epilepsy Behav. 2013;28:81-86.
  • [DeLorenzo et al., 1995] DeLorenzo R.J., Pellock J.M., Towne A.R., Boggs J.G. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316-325.
  • [Deonna et al., 1986] Deonna T., Ziegler A.L., Despland P.A., van Melle G. Partial epilepsy in neurologically normal children: clinical syndromes and prognosis. Epilepsia. 1986;27:241-247.
  • [Dziewas et al., 2002] Dziewas R., Kellinghaus C., Lüdemann P. Nonconvulsion status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies. Seizure. 2002;11:335-339.
  • [Eriksson et al., 2005] Eriksson K., Metsäranta P., Huhtala H., Auvinen A., Kuusela A.L., Koivikko M. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65:1316-1318.
  • [Ferrie et al., 1997] Ferrie C.D., Beaumanoir A., Guerrini R. Early-onset benign occipital seizure susceptibility syndrome. Epilepsia. 1997;38:285-293.
  • [Fountain, 2000] Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia. 2000;41:23-30.
  • [Genton et al., 2000] Genton P., Gelisse P., Thomas P., Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?. Neurology. 2000;55:1106-1109.
  • [Genton et al., 2001] Genton P., Thomas P., Kasteleijn-Nolst Trenité D.G., Medina M.T., Salas-Puig J. Clinical aspects of juvenile myoclonic epilepsy. Epilepsy Behav. 2001;28:8-14.
  • [Hauser et al., 1997] Hauser W.A., Rich S.S., Annegers J.F., Anderson V.E. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1997;40:1163-1170.
  • [Hesdorffer et al., 1998] Hesdorffer D.C., Logroscino G., Cascino G., Annegers J.F., Hauser W.A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology. 1998;50:735-741.
  • [Hesdorffer et al., 2007] Hesdorffer D.C., Logroscino G., Cascino G.D., Hauser W.A. Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology. 2007;69:73-78.
  • [Larch et al., 2009] Larch J., Unterberger I., Bauer G. Myoclonic status epilepticus in juvenile myoclonic epilepsy. Epileptic Disord. 2009;11:309-314. 10.1684/epd.2009.0284
  • [Lee et al., 2013] Lee D., Gladwell D., Batty A.J., Brereton N., Tate E. The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited. Paediatr Drugs. 2013;15:151-162.
  • [Loiseau et al., 1983] Loiseau P., Pestre M., Dartigues J.F. Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol. 1983;13:642-648.
  • [Loiseau et al., 1995] Loiseau P., Duché B., Pédespan J.M. Absence epilepsies. Epilepsia. 1995;36:1182-1186.
  • [Lowenstein et al., 1999] Lowenstein D.H., Bleck T., Macdonald R.L. Its time to revise the definition of status epilepticus. Epilepsia. 1999;40:120-122.
  • [Novak et al., 1997] Novak G., Maytal J., Alshansky A., Ascher C. Risk factors for status epilepticus in children with symptomatic epilepsy. Neurology. 1997;49:533-537.
  • [Panayiotopoulos et al., 1997] Panayiotopoulos C.P., Agathonikou A., Sharoqi I.A., Parker A.P. Vigabatrin aggravates absences and absence status. Neurology. 1997;49:1467.
  • [Peters et al., 2001] Peters J.M., Camfield C.S., Camfield P.R. Population study of benign rolandic epilepsy: is treatment needed?. Neurology. 2001;57:537-539.
  • [Shinnar, 2007] Shinnar S. Who is at risk for prolonged seizures?. J Child Neurol. 2007;22:14-20.
  • [Shinnar et al., 1990] Shinnar S., Berg A.T., Moshé S.L. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics. 1990;85:1076-1085.
  • [Shinnar et al., 1996] Shinnar S., Berg A.T., Moshé S.L. The risk of seizure recurrence after a first unprovoked febrile seizure in childhood: an extended follow-up. Pediatrics. 1996;98:216-225.
  • [Shinnar et al., 1997] Shinnar S., Pellock J.M., Moshé S.L. In whom does status epilepticus occur: age-related differences in children. Epilepsia. 1997;38:907-914.
  • [Shinnar et al., 2001] Shinnar S., Berg A.T., Moshé S.L., Shinnar R. How long do new-onset seizures in children last?. Ann Neurol. 2001;49:659-664.
  • [Shorvon and Walker, 2005] Shorvon S., Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia. 2005;46:73-79.
  • [Sillanpää and Shinnar, 2002] Sillanpää M., Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol. 2002;52:303-310.
  • [Stroink et al., 2007] Stroink H., Geerts A.T., van Donselaar C.A. Status epilepticus in children with epilepsy: Dutch study of epilepsy in childhood. Epilepsia. 2007;48:1708-1715.
  • [Thomas et al., 2006] Thomas P., Valton L., Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006;129:1281-1292.
  • [Trinka et al., 2004] Trinka E., Baumgartner S., Unterberger I., Unterrainer J., Luef G. Long-term prognosis for childhood and juvenile absence epilepsy. J Neurol. 2004;251:1235-1241.
  • [Valentin et al., 2007] Valentin A., Hindocha N., Osei-Lah A. Idiopathic generalized epilepsy with absences: syndrome classification. Epilepsia. 2007;48:2187-2190.
  • [Wirrell et al., 1995] Wirrell E.C., Camfield P.R., Gordon K.E., Dooley J.M., Camfield C.S. Benign rolandic epilepsy: atypical features are very common. J Child Neurol. 1995;10:455-458.
  • [Wirrell et al., 1996] Wirrell E.C., Camfield C.S., Camfield P.R., Gordon K.E., Dooley J.M. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology. 1996;47:912-918.
  • [Wirrell et al., 2011] Wirrell E.C., Grossardt B.R., So E.L., Nickels K.C. A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: cryptogenic epilepsy is probably not symptomatic epilepsy. Epilepsia. 2011;52:738-745.